Palisade Bio annual revenue
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2022
2023
2024
2025
Palisade Bio Revenue Growth & History (PALI)
Palisade Bio reported $0 in revenue for fiscal 2025.
View full Palisade Bio company overviewPalisade Bio annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | −$250,000 | −100.00% |
| 2023 | 2023-12-31 | $250,000 | $250,000 | — |
| 2022 | 2022-12-31 | $0 | — | — |
| 2020 | 2020-12-31 | $13,520 | −$1,874 | −12.17% |
| 2019 | 2019-12-31 | $15,394 | −$244,606 | −94.08% |
| 2018 | 2018-12-31 | $260,000 | $0 | 0.00% |
| 2017 | 2017-12-31 | $260,000 | $243,754 | +1500.39% |
| 2016 | 2016-12-31 | $16,246 | $5,829 | +55.96% |
| 2015 | 2015-12-31 | $10,417 | −$8,416 | −44.69% |
| 2014 | 2014-12-31 | $18,833 | −$91,167 | −82.88% |
| 2013 | 2013-12-31 | $110,000 | −$297,708 | −73.02% |
| 2012 | 2012-12-31 | $407,708 | $17,083 | +4.37% |
| 2011 | 2011-12-31 | $390,625 | −$342,813 | −46.74% |
| 2010 | 2010-12-31 | $733,438 | — | — |
Palisade Bio quarterly revenue
Q2.11
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $500,000 | $500,000 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q1 2025 | 2025-03-31 | $0 | $0 | — |
| Q4 2024 | 2024-12-31 | $0 | $0 | — |
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q2 2024 | 2024-06-30 | $0 | $0 | — |
| Q1 2024 | 2024-03-31 | $0 | −$250,000 | −100.00% |
| Q4 2023 | 2023-12-31 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q2 2023 | 2023-06-30 | $0 | $0 | — |
| Q1 2023 | 2023-03-31 | $250,000 | $250,000 | — |
| Q4 2022 | 2022-12-31 | $0 | — | — |
| Q3 2022 | 2022-09-30 | $0 | — | — |
| Q2 2022 | 2022-06-30 | $0 | — | — |
| Q1 2022 | 2022-03-31 | $0 | — | — |
| Q4 2020 | 2020-12-31 | $2,500 | $0 | 0.00% |
| Q3 2020 | 2020-09-30 | $2,500 | $0 | 0.00% |
| Q2 2020 | 2020-06-30 | $2,500 | −$5,394 | −68.33% |
| Q1 2020 | 2020-03-31 | $6,020 | $3,520 | +140.80% |
| Q4 2019 | 2019-12-31 | $2,500 | $0 | 0.00% |
| Q3 2019 | 2019-09-30 | $2,500 | $0 | 0.00% |
| Q2 2019 | 2019-06-30 | $7,894 | −$244,606 | −96.87% |
| Q1 2019 | 2019-03-31 | $2,500 | $0 | 0.00% |
| Q4 2018 | 2018-12-31 | $2,500 | −$250,000 | −99.01% |
| Q3 2018 | 2018-09-30 | $2,500 | $0 | 0.00% |
| Q2 2018 | 2018-06-30 | $252,500 | $250,000 | +10000.00% |
| Q1 2018 | 2018-03-31 | $2,500 | $0 | 0.00% |
| Q4 2017 | 2017-12-31 | $252,500 | $243,754 | +2787.03% |
| Q3 2017 | 2017-09-30 | $2,500 | $0 | 0.00% |
| Q2 2017 | 2017-06-30 | $2,500 | $0 | 0.00% |
| Q1 2017 | 2017-03-31 | $2,500 | $0 | 0.00% |
| Q4 2016 | 2016-12-31 | $8,746 | $6,246 | +249.84% |
| Q3 2016 | 2016-09-30 | $2,500 | $0 | 0.00% |
| Q2 2016 | 2016-06-30 | $2,500 | $0 | 0.00% |
| Q1 2016 | 2016-03-31 | $2,500 | −$417 | −14.30% |
| Q4 2015 | 2015-12-31 | $2,500 | −$2,166 | −46.42% |
| Q3 2015 | 2015-09-30 | $2,500 | −$2,500 | −50.00% |
| Q2 2015 | 2015-06-30 | $2,500 | −$2,500 | −50.00% |
| Q1 2015 | 2015-03-31 | $2,917 | −$1,250 | −30.00% |
| Q4 2014 | 2014-12-31 | $4,666 | $2,166 | +86.64% |
| Q3 2014 | 2014-09-30 | $5,000 | $2,500 | +100.00% |
| Q2 2014 | 2014-06-30 | $5,000 | $2,500 | +100.00% |
| Q1 2014 | 2014-03-31 | $4,167 | −$98,333 | −95.93% |
| Q4 2013 | 2013-12-31 | $2,500 | $0 | 0.00% |
| Q3 2013 | 2013-09-30 | $2,500 | −$168,333 | −98.54% |
| Q2 2013 | 2013-06-30 | $2,500 | −$75,625 | −96.80% |
| Q1 2013 | 2013-03-31 | $102,500 | −$53,750 | −34.40% |
| Q4 2012 | 2012-12-31 | $2,500 | — | — |
| Q3 2012 | 2012-09-30 | $170,833 | $67,416 | +65.19% |
| Q2 2012 | 2012-06-30 | $78,125 | $78,125 | — |
| Q1 2012 | 2012-03-31 | $156,250 | — | — |
| Q3 2011 | 2011-09-30 | $103,417 | — | — |
| Q2 2011 | 2011-06-30 | $0 | — | — |
Palisade Bio revenue growth trends
Palisade Bio's latest reported quarter, Q2 2026, generated $500,000 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Palisade Bio source filings ↗